Latest Milan News

Page 2 of 2
Vmoto Limited reports a robust sales rebound in the final quarter of 2025, with a 68% jump in units sold and a near doubling of firm orders, underpinned by strategic partnerships and expanding manufacturing capacity.
Victor Sage
Victor Sage
4 Feb 2026
OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.
Ada Torres
Ada Torres
30 Jan 2026
OncoSil Medical’s interim OSPREY registry data reveals promising survival improvements for patients with unresectable locally advanced pancreatic cancer treated with OncoSil™ plus chemotherapy. The findings suggest a meaningful step forward in a field with limited effective options.
Ada Torres
Ada Torres
3 Dec 2025
Vection Technologies has secured $1.5 million in AI-driven enterprise orders spanning agritech, cybersecurity, real estate, healthcare, and public administration, reinforcing its recurring revenue model and cross-sector appeal.
Sophie Babbage
Sophie Babbage
20 Oct 2025
Syntara Limited is set to reveal fresh interim results from its Phase 2 trial of SNT-5505, targeting myelofibrosis, during an investor webinar ahead of a major European hematology conference.
Ada Torres
Ada Torres
13 June 2025
Vection Technologies has successfully raised $3.55 million, exceeding its initial $2 million target, following a robust Q3 FY25 performance marked by a 92% increase in cash receipts and a significant boost in recurring revenue.
Sophie Babbage
Sophie Babbage
29 Apr 2025
Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.
Sophie Babbage
Sophie Babbage
12 Feb 2025
Vmoto reports a 33% decline in FY24 unit sales but maintains operational cash flow positivity and secures new joint ventures in Thailand and Mexico to bolster its electric mobility footprint.
Victor Sage
Victor Sage
4 Feb 2025
OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.
Victor Sage
Victor Sage
30 Jan 2025

Browse the archive

Full archive